Loading...
Thumbnail Image
Publication

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly

Blanco, Jorge C G
Cullen, Lori M
Kamali, Arash
Sylla, Fatouomata Y D
Boukhvalova, Marina S
Morrison, Trudy G
Citations
Google Scholar:
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
2023-05-31
Subject Area
Embargo Expiration Date
Abstract

Respiratory syncytial virus (RSV) is a significant threat to elderly populations and repeated infections that occur throughout life are poorly protective. To assess the role of prior RSV infections as well as elderly immune senescence on vaccine efficacy, we compared immune responses after virus-like particle (VLP) immunization of elderly cotton rats and young cotton rats, both previously RSV infected, in order to mimic the human population. We show that immunization of RSV-experienced young or elderly animals resulted in the same levels of anti-pre-F IgG, anti-G IgG, neutralizing antibody titers, and protection from challenge indicating that the delivery of F and G proteins in a VLP is equally effective in activation of protective responses in both elderly and young populations. Our results suggest that F and G protein-containing VLPs induce anti-RSV memory established in prior RSV infections equally well in both young and elderly animals and thus can be an effective vaccine for the elderly.

Source

Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. 2023 May 31;15(6):1305. doi: 10.3390/v15061305. PMID: 37376605; PMCID: PMC10304043.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.3390/v15061305
PubMed ID
37376605
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Attribution 4.0 International